Key Highlights

  • Flowers Foods reported second-quarter adjusted Diluted Earnings per Share of $0.21, down from $0.30 in the prior-year period.
  • Net sales declined 4.0 percent to $1.193 billion, as favourable pricing and mix were more than offset by a 5.8 percent Volume decline.
  • Adjusted EBITDA fell 19.2 percent to $111.3 million, with adjusted EBITDA Margin contracting 180 basis points to 9.3 percent.
  • The company lowered full-year adjusted EPS guidance to a range of $0.75 to $0.85, down from a prior range of $0.80 to $0.90.

Fresh Packaged Bread Category Pressure Weighs on a Challenging Quarter

Flowers Foods, Inc. (NYSE:FLO), the Georgia-based baker behind brands including Nature's Own, Dave's Killer Bread, and Wonder, reported second-quarter results that fell short of internal expectations, as persistent pressure across the fresh packaged bread category weighed on both volume and profitability. Official data show net sales declining 4.0 percent to $1.193 billion for the 12-week period, with branded retail sales down 3.8 percent and other net sales down 4.4 percent.

Company officials described the operating environment as more difficult than anticipated, citing household budget pressure, evolving consumer preferences, and sustained competitive activity. The results follow a broader strategic review the company describes as newly concluded, with several resulting initiatives, including realigned organizational structure and cost actions, now moving into execution.

Volume Declines Outpace Pricing Gains as Category Shifts Toward Sourdough

Net sales pressure stemmed primarily from volume, which declined 5.8 percent, more than offsetting a 1.8 percent gain from favourable pricing and mix. Fresh bread volume alone fell 9.5 percent during the quarter, a decline company officials linked in part to the rapid growth of the sourdough sub-category, now estimated at $1.3 billion, an area where the company's Dave's Killer Bread Brand currently has limited geographic distribution.

Materials, supplies, labor, and other production costs rose to 51.6 percent of net sales, a 40 basis point increase, reflecting lower production volumes and higher labor costs, partially offset by moderating ingredient costs. Selling, distribution, and administrative expenses increased 160 basis points to 39.7 percent of net sales, driven by higher Marketing spend and workforce-related costs.

Adjusted Net Income fell 30.5 percent to $44.1 million, while adjusted EBITDA margin contracted 180 basis points to 9.3 percent. Cash and cash equivalents stood at $52.8 million at quarter end, with year-to-date Operating Cash Flow of $241.5 million.

New Business Wins and Innovation Pipeline Aim to Offset Category Headwinds

Management pointed to several factors that may support sequential improvement in the second half, including new business wins already contracted for the period, additional cost savings measures beyond the roughly $200 million already realized in recent years, and an expanded innovation pipeline addressing smaller formats, sourdough, and protein-forward products. The relaunch of Nature's Own, still in early stages, has generated positive customer feedback, though management cautioned that meaningful financial contribution has not yet materialized.

These initiatives could support the stabilization management is guiding toward in the fourth quarter, following an expected continued year-over-year sales decline in the third quarter. However, rising input costs, particularly in oil, diesel, and resin-linked packaging, may pressure margins further into 2027 if pricing alone proves insufficient to offset inflation, a concern company officials acknowledged remains under active review. Continued private label trade-down among consumers also remains a risk to branded volume recovery.

Conclusion

Flowers Foods' second quarter reflects a packaged bakery business navigating a structurally shifting category, where consumer preference for attributes such as sourdough and protein has outpaced the company's own innovation pipeline. The lowered full-year guidance signals a more cautious near-term outlook, even as management points to new business wins and product launches as potential levers for stabilization. Whether these initiatives can offset continued volume pressure is likely to become more apparent as fourth-quarter results reflect the fuller rollout of innovation and realigned cost structure.